Download | < Back |
03 Jul 2014 | |
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 03, 2014, titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials" | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |